Veriheal

JUNE 22, 2020

So when she was approached with an unusual therapy to help with his treatment, she agreed. Not only was it found to be effective in many cases, but it was also even shown to be effective against some conditions that had not responded to traditional therapies. Cannabis as a Treatment for Seizures. What This Means Going Forward.

Therapy 76

Therapy Treatment Research and Development Conditions 76

The Fresh Toast

FEBRUARY 23, 2019

Marijuana’s CBD Can Help Sufferers Of Lennox–Gastaut Syndrome A study published in the New England Journal of Medicine explored the potential for CBD combined with current medicine therapies to help patients with this severe form of epilepsy.

CBD 91

CBD Epilepsy Therapy Medicine 91

Leafwell

JANUARY 14, 2021

It seems that every day further therapeutic properties of the marijuana plant’s hundreds of cannabinoids are discovered and development begins on the next marijuana wonder therapy. One group of patients needs that medical.

Epilepsy 52

Epilepsy Chronic Pain Therapy Treatment 52

MMJ Recs

NOVEMBER 2, 2023

The real stories around medical marijuana (MMJ) are those of the patients who have experienced life-changing benefits from cannabis therapy. In this article, we’ll explore MMJ patient success stories in West Virginia and how cannabis therapy is positively impacting patients’ lives.

Patients 98

Patients Chronic Pain Therapy Treatment 98

United Patients Group

JULY 7, 2023

3) Helps Manage Nausea and Vomiting Medical cannabis can be used to manage nausea and vomiting associated with chemotherapy, radiation therapy, and other medical treatments. 4) Reduces Seizures in Epilepsy Medical cannabis can be used to manage seizures in people with epilepsy.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.

Epilepsy 40

Epilepsy Clinical Trials Research and Development Pharmaceutical 40

Veriheal

OCTOBER 30, 2023

They will now be allowed to prescribe medical cannabis to treat conditions like depression, epilepsy, multiple sclerosis, post-traumatic stress disorder , and cancer. These bills will make way for Bahamians to access these essential therapies to improve the quality of HealthCare Delivery System.”

Legalization 119

Legalization Therapy Decriminalization Epilepsy 119

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Under the Leadership of Nicolas Schlienz, Ph.D., COLORADO SPRINGS, Colo.–(BUSINESS

Data 81

Data Epilepsy Research and Development Clinical Trials 81

MMJ Recs

NOVEMBER 20, 2023

Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition. For example, the discovery of CBD’s effectiveness in managing epilepsy led to the development of Epidiolex, the first FDA-approved medication derived from marijuana.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Cannabis Law Report

JANUARY 26, 2022

MDMA as an adjunct to therapy for PTSD is the forty-first treatment to receive the Innovation Passport since its inception in January 2021. The Innovative Licensing and Access Pathway (ILAP) Innovation Passport has ben granted to MDMA as an adjunct to therapy for posttraumatic stress disorder (PTSD) in the United Kingdom (UK).

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

The Cannigma

JUNE 1, 2021

Some of the qualifying health conditions include epilepsy, neuropathic pain, chemotherapy side effects, a need for palliative care, and pain linked to multiple sclerosis, according to France24. Children may be eligible in cases of refractory epilepsy or cancer. Who can get medical cannabis in France? .

Law 112

Law Epilepsy Programs Patients 112

Cannabis Law Report

AUGUST 31, 2021

For her part, Marie Millard, executive director of the Luces Panama Foundation, said that the approval of the legislative initiative will give patients quality of life, specifically for people with epilepsy who take two and three medications and do not work for them.

Legalization 100

Legalization Epilepsy Medicine Chronic Pain 100

Kind Meds (Cannabis Education Blog)

AUGUST 24, 2018

Severe nausea; Seizures, including those characteristic of epilepsy. Severe or persistent muscle spasms, including those characteristic of multiple sclerosis, severe and chronic pain is already being treated in Arizona with therapeutic and clinical therapies in conjunction with marijuana therapy.

Chronic Pain 99

Chronic Pain Marijuana Therapy Treatment 99

Puff Puff Post

OCTOBER 3, 2019

Previous success from treating epilepsy with Cannabinoids now motivates doctors to investigate the plant’s effectiveness in treating symptoms of autism. Epidiolex is a CBD-infused oral-based medication designed to help patients as young as two-years-old treat epilepsy disorders.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. References Staff, T.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Cannabis Law Report

SEPTEMBER 12, 2021

For several millennia, humans have used cannabinoids for pain, epilepsy, gastrointestinal disorders, and even infections. A small yet growing body of research indicates that CBD is a safe and effective treatment for lameness and epilepsy in dogs, Dr. Boothe said, but more studies are needed to bear this out. “I

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

MedicalJane

OCTOBER 19, 2022

Cancer, including remission therapy. Opioid use disorder for which conventional therapeutic interventions are contraindicated or ineffective, or for which adjunctive therapy is indicated in combination with primary therapeutic interventions. Anxiety disorders. Crohn’s disease. Dyskinetic and spastic movement disorders. HIV / AIDS.

Marijuana 99

Marijuana Therapy Programs Patients 99

Cannabis Law Report

JUNE 5, 2021

After leaving their home in Northern Ireland, Charlotte Caldwell and 15-year-old Billy, who suffers from refractory epilepsy and autism, have crossed by ferry to Great Britain on an expedition scheduled to end at the Houses of Parliament at Westminster on June 14. The Caldwells have three primary goals in mind as they journey across the U.K.

Access 104

Access Epilepsy Therapy Medicine 104

MMJ Recs

NOVEMBER 17, 2023

Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies. MMJ is known for its efficacy in treating various medical issues, including chronic pain, epilepsy, multiple sclerosis, and more.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Green Relief

FEBRUARY 20, 2018

My knowledge of Epigenetics has has since crossed over another area of passion: medical cannabis therapy. Of course, unique varieties of cannabis exert varying effects on individuals, an issue that may be solved through a new process that allows for genetic individualization of cannabis therapy.

Therapy 40

Therapy Cannabinoids Cannabis Terpenes 40

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Veriheal

MARCH 10, 2021

There’s a fair amount of room for interpretation in that, but we can assume that veterinarians would use the bill to certify animals with such conditions as epilepsy , chronic pain , severe anxiety , and more for cannabis treatments. Implications for the Future.

Pets 52

Pets Therapy Treatment Chronic Pain 52

MMJ Recs

MAY 25, 2024

However, dysregulation of the endocannabinoid system has been implicated in the pathogenesis of neurological disorders such as epilepsy, multiple sclerosis, Parkinson’s disease, and Alzheimer’s disease. Overall, by targeting the ECS, cannabis therapy offers a holistic approach to symptom relief for various medical conditions.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

MassRoots

AUGUST 3, 2020

Previously, the number of physicians that were allowed to recommend medical marijuana therapy was limited and so were the conditions that would qualify a person for the program. Only two facilities are allowed to cultivate medical cannabis for the entire state, and only nine pharmacies are licensed to distribute it to patients.

Programs 124

Programs Banking Marijuana Conditions 124

MMJ Recs

DECEMBER 28, 2023

Image by Budding on Unsplash CBD for Epilepsy: Insights into Its Anticonvulsant Properties Epilepsy is a neurological disorder characterized by recurrent seizures, and for some patients, conventional treatments may be inadequate.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

MassRoots

FEBRUARY 17, 2019

Conditions that qualify for the medical marijuana program in Pennsylvania include: Amyotrophic lateral sclerosis (ALS) Autism Cancer, including remission therapy Crohn’s disease Damage to the nervous tissue of the central nervous system (brain-spinal cord) Dyskinetic and spastic movement disorders Epilepsy Glaucoma HIV / AIDS Huntington’s (..)

Marijuana 105

Marijuana Programs Dispensary Collective 105

The Cannigma

JULY 17, 2022

You don’t need a medical condition or a paid subscription – the ROC serves curious consumers, medical professionals, and anyone else who is looking to better their life through cannabinoid therapies.

Advocacy 120

Advocacy Education Events Epilepsy 120

The Joint Blog

JANUARY 31, 2021

The study is titled A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extract as complementary therapy: A case report. For the study researchers studied the effects of marijuana extracts in a fifteen-year-old who suffered from autism, anxiety, and controlled epilepsy. ml twice daily.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

Veriheal

APRIL 11, 2022

I look forward to a time when they are not considered alternative therapies or home remedies but actually first-line therapies,” said the CEO of Zelira, Oludare Odumosu. “I look forward to a time when they are not considered alternative therapies or home remedies but actually first-line therapies,” said the CEO of Zelira, Oludare Odumosu. “We

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Cannabis Law Report

SEPTEMBER 9, 2021

MYMD-1 is also being developed as a potential therapy for COVID-19-related conditions such as post-COVID-19 syndromes. Supera-CBD is being developed to address anxiety, chronic pain, addiction, and seizures, and is on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain.

Pharmaceutical 74

Pharmaceutical Clinical Trials Chronic Pain Epilepsy 74

United Patients Group

AUGUST 28, 2023

Potential Benefits of CBD for Pets As interest in CBD as a pet therapy continues to grow, both veterinarians and pet owners are beginning to explore the myriad potential benefits of this plant-based medicine. Some of the most common health issues that may potentially be addressed by CBD for pets include: 1.

Pets 97

Pets CBD Chronic Pain Digestion 97

Leaf Science

JULY 12, 2019

While little is known about the successes of ancient Egyptian cancer treatments, cannabis continues to receive significant interest as a cancer therapy today. After studying its effects, he introduced cannabis to physicians in England as a treatment for a wide range of conditions, including muscle spasms, rheumatism, epilepsy and pain.

Indica 95

Indica Marijuana Treatment Medicine 95

NORML

MAY 24, 2019

The measure would permit physicians to recommend cannabis therapy to those diagnosed with anxiety, autism, opioid addiction or dependence, anorexia nervosa, among others. Click here to email your lawmakers in support of employment protections. Update : SB 430 was approved by the Assembly Health and Human Services Committee on 5/21/19.

Legislation 192

Legislation Hemp Access Patients 192

CannaMD

JUNE 1, 2020

Further, there is no known cure for autism — just medications and therapies that serve to make life more manageable. Perhaps with CBD’s favorable impacts on epilepsy in mind, study authors were quick to note that “non-epileptic autism [may share] underlying etiological mechanisms” with epileptic diseases.

CBD 111

CBD Sleep Extraction Treatment 111

Cannabis Law Report

SEPTEMBER 20, 2021

Nanomerics”) to use Nanomeric’s molecular envelope platform technology (MET) for the nasal delivery of a cannabidiol (CBD) for the management of epilepsy in adults and children. Food and Drug Administration’s review. “We Mack, Chairman and CEO of Virpax.

Epilepsy 40

Epilepsy Research and Development Clinical Trials Chronic Pain 40

Veriheal

MAY 17, 2021

Some of the diseases and conditions that would qualify Alabama citizens for medical cannabis patient status include but are not limited to Crohn’s disease , panic disorder , epilepsy , depression , or any condition in which chronic pain is experienced, and opioids have been ineffective.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

Cannabis Law Report

OCTOBER 19, 2021

Unlike other therapies, MYMD-1 has been shown to selectively block TNF-? In addition, the drug is not immunosuppressive and has not been shown to cause the serious side effects common with traditional therapies that treat inflammation. a driver of chronic inflammation. No approved TNF inhibitor has ever been dosed orally.

Pharmaceutical 40

Pharmaceutical Therapy Clinical Trials Chronic Pain 40